Trials / Completed
CompletedNCT04306497
TCM Differentiation and Treatment Protocol of COVID-19
Clinical Trial of TCM Differentiation and Treatment Protocol of COVID-19 in Jiangsu Province
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 340 (actual)
- Sponsor
- Jiangsu Famous Medical Technology Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the efficacy and safety of TCM differential treatment of COVID-19 in Jiangsu Province based on the historical prospective multicenter cohort study.
Detailed description
This is a multi-center cross-sectional syndrome investigation study, taking confirmed cases as the main observation object, A prospective multicenter cohort study was designed, focusing on the common type with the largest number of confirmed cases, to evaluate the intervention effect of this project in relieving the disEvaluation of the efficacy and safety of TCM differential treatment of COVID-19 inease and preventing disease progressio. According to the actual situation of receiving treatment, if the subjects received the combination of western medicine and traditional Chinese medicine, it was the exposure group (integrated traditional Chinese and western medicine cohort), and if the subjects only received western medicine treatment, it was the control group (western medicine cohort). The choice of treatment for patients is entirely determined by clinicians according to the patient's condition, and patients are free to choose after fully understanding different schemes).The choice of control group: COVID-19 (common type) who received routine treatment + antiviral therapy；The choice of exposure group: COVID-19 (common type) who received routine treatment + TCM.The sample size is tentatively set at 340.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TCM prescriptions | TCM prescriptions1:Take decocted or granule, one dose a day; TCM prescriptions2:Take decocted or granule, one dose a day. |
Timeline
- Start date
- 2020-01-22
- Primary completion
- 2020-04-30
- Completion
- 2020-05-30
- First posted
- 2020-03-13
- Last updated
- 2020-06-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04306497. Inclusion in this directory is not an endorsement.